HIV

Idvynso
Apr 23, 2026

Merck wins FDA approval for once-daily HIV pill Idvynso

The clearance for Idvynso, which combines doravirine and islatravir for adults with HIV-1, helps expand treatment options for patients.

Integrity House's community health hub
Mar 7, 2026

Integrity House kiosk in Newark offers naloxone, HIV tests (updated)

Integrity House launched a kiosk at University Hospital in Newark to provide naloxone, HIV test kits, and free prevention and wellness resources.